Login / Signup
John F Marcelletti
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 3
Top Topics
Acute Myeloid Leukemia
Clinical Trial
Low Dose
Allogeneic Hematopoietic Stem Cell Transplantation
Top Venues
Cancer chemotherapy and pharmacology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
John F Marcelletti
,
Branimir I Sikic
Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype.
Cancer chemotherapy and pharmacology
93 (6) (2024)
John F Marcelletti
,
Branimir I Sikic
Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype.
Cancer chemotherapy and pharmacology
(2024)
John F Marcelletti
,
Branimir I Sikic
A clinical trial of zosuquidar plus gemtuzumab ozogamicin (GO) in relapsed or refractory acute myeloid leukemia (RR AML): evidence of efficacy based on leukemic blast P-glycoprotein functional phenotype.
Cancer chemotherapy and pharmacology
(2023)